Publications

Journal Article Review Epublish 85 citations

PubMed: 34305576 DOI: 10.3389/fnagi.2021.702231

Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction.

Front Aging Neurosci 13:702231

Authors: Cong-Mei Wang, Wei-Can Chen, Yan Zhang, Shu Lin, He-Fan He

Affiliations

  • Department of Anesthesiology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
  • Department of Anesthesiology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China. Diabetes and Metabolism Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, NSW, Australia. Centre of Neurological and Metabolic Research, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

Abstract

Sevoflurane is one of the most widely used anesthetics for the induction and maintenance of general anesthesia in surgical patients. Sevoflurane treatment may increase the incidence of postoperative cognitive dysfunction (POCD), and patients with POCD exhibit lower cognitive abilities than before the operation. POCD affects the lives of patients and places an additional burden on patients and their families. Understanding the mechanism of sevoflurane-induced POCD may improve prevention and treatment of POCD. In this paper, we review the diagnosis of POCD, introduce animal models of POCD in clinical research, analyze the possible mechanisms of sevoflurane-induced POCD, and summarize advances in treatment for this condition.

MeSH

Therapeutics, Cognitive Dysfunction, Sevoflurane, Postoperative Cognitive Complications

Cited by